Correct on the preliminary meeting. In the super stock webinar NP was asked about the BTD and that's where he said they didn't have enough patient/data, so it was a soft "no" because they did get a request to have a preliminary meeting. I think you can still find the webinar on YouTube if you didn't get a chance to tune in live.